🔴 Chimeric Therapeutics is trading 25% down today after continued selling

Chimeric Therapeutics is trading 25% down at A$0.01 after continued selling following the unexplained September 4, 2026 decline.

• The September 4 filing concerned an application to quote 14,814,814 new shares, which may have increased supply, but no verified announcement directly links it to the September 7, 2026 move.
• The earlier decision to halt CHM-2101 trial enrolment after a second dose-limiting toxicity remains negative background news, not a new September 7 catalyst.